Democritus University of Thrace (DUTH)
Η εφαρμογή της υποδόριας χορήγησης ερυθροποιητίνης σε ασθενείς που υποβάλλονται σε συνεχή φορητή περιτοναϊκή κάθαρση
Abstract
dc:descriptionTHIS STUDY WAS DESIGNED TO EVALUATE THE TOTAL ACTION OF THE ADMINISTRATION OF RECOMBINANT HUMAN ERYTHROPOIETIN (RHUPOE) FOR THE CORRECTION OF ANEMIA IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL DIALYSIS(CAPD). 12 CAPD PATIENTS WITH ANEMIA WERE EVALUATED. IN THESE PATIENTS AN INITIAL DOSE OF 50 U/KG RHUEPO WAS SUBCUTANEOUSLY ADMINISTERED, TWICE A WEEK. EXCEPT FOR THE HEMATOLOGICAL EVALUATION, THE PERITONEAL KINETIC PARAMETER MODIFICATIONS AND THE BIOCHEMICAL SERUM VALUES CHANGES WERE ALSO MEASURED, BEFORE AND AFTER THE CORRECTION OF ANEMIA. IN ADDITION THE PSYCHOLOGICAL STATUS OF THE PATIENTS AND THE CAUSES OF DRUG-REFRACTORY EFFECT WERE EVALUATED. A STATISTICALLY SIGNIFICANT INCREASE IN HEMATOCRIT AND HEMOGLOBIN VALUES WITH THE SUBCUTANEOUS ADMINISTRATION OF RHUEPO WAS ESTABLISHED BY THE RESULTS OF THE STUDY, WHILE THERE WAS OBSERVED A SIGNIFICANT INCREASE IN PERITONEAL MASS TRANSPORT OF UREA ANDCREATININE CORRESPONDING WITH OPPOSITE CHANGES IN SERUM VALUES OF THESE SUBSTANCES. AN IMPROVEMENT IN PATIENTS' DEPREASSIVE MOOD WAS ALSO RECORDED. THERE WASN'T SEEN ANY SERIOUS ADVERSE REACTIONS, DURING THE THERAPY EXCEPT FOR ANINCREASE OF ARTERIAL PRESSURE THAT WAS OBSERVED IN SOME PATIENTS. LATE DRUG RESISTANCE WAS ALSO ESTIMATED IN FEW PATIENTS DURING THE COURSE OF INFECTION AND IN THE PRESENCE OF SECONDARY HYPERPARATHYROIDISM. THESE OBSERVATIONS SUGGEST THAT THE TWICE A WEEK SUBCUTANEOUS ADMINISTRATION OF RHUEPO IN CAPD PATIENTS IS EFFECTIVE IN ANEMIA CORRECTION, WHILE THERE IS ABSTRACT TRUNCATED
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 1996
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Παναγούτσος, Στυλιανός
Subjects
dc:subject × 18Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/8155